Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

novartis ireland ltd - ofatumumab - Множествена Склероза, Рецидивно-Ремиттирующее - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

stemline therapeutics b.v. - selinexor - Множествена миелома - Антинеопластични средства - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - Множествена Склероза, Рецидивно-Ремиттирующее - Имуносупресори - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

mylan ireland limited - финголимод хидрохлорид - Множествена Склероза, Рецидивно-Ремиттирующее - Имуносупресори - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 и 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - Множествена миелома - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Bulgarija - bulgarų - БАБХ (Българска агенция по безопасност на храните)

Биовет АД - Гентамицина сулфат - инжекционен разтвор - 100 mg/ml - биволи, говеда, котки, кучета, свине

Bulgarija - bulgarų - БАБХ (Българска агенция по безопасност на храните)

Завет АД - Хидрохлорид линкомицина, гентамицина сулфат, ацетат преднизолона - интрамамарна маз - 250 000 iu/8 g; 80 000 iu/8 g; 5.4 mg/8 g - говеда

Bulgarija - bulgarų - БАБХ (Българска агенция по безопасност на храните)

ВЕТПРОМ АД - Тетрациклин хидрохлорид; фосфат Олеандомицина; хидрокортизон ацетат - аерозол - 1,5 g/150 g; 0,75 g/150 g; 0,1 g/150 g; 0,9 g/90 g; 0, 45 g/90 g; 0, 06 g/90 g - котки, кучета

Bulgarija - bulgarų - БАБХ (Българска агенция по безопасност на храните)

ВЕТПРОМ АД - Тиамфениколом, тиамин хидрохлорид, рибофлавин , piridoxine хидрохлорид, никотинамид Викасол - таблетки - 200 000 iu (0.200 g)/0.7 g; 0.0025g/0.7 g; 0.0025g/0.7 g; 0.0050g/0.7 g; 0.0025 g/0.7 g; 0.0150 g /0.7 g - агнета, котки, кучета, телета, ярета

Bulgarija - bulgarų - БАБХ (Българска агенция по безопасност на храните)

Биовет АД - Тилмикозин (под формата на фосфат) - премикс за медикаментозен фураж - 100 mg/g - свине